Kenmerk
Muscle ache
Klinische naam: Myalgia
Pain in muscle.
Samenvatting
- Ook bekend als
- Muscle pain
- Lichaamssysteem
- Constitutional symptom
ReferentiegenoomGRCh38hg38
Posities op gen- en variantpagina's volgen deze keuze, in deze browser.
Read the genes linked to Muscle ache, and the rest of your genome, with one test.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken
Mijn Genome Test bestellen176 genen gekoppeld aan Muscle ache
Veranderingen in deze genen veroorzaken zeldzame aandoeningen waarbij Muscle ache voorkomt. De meeste mensen met dit kenmerk hebben geen van die aandoeningen, en een gen op deze lijst zegt niets over het eigen genoom van iemand.
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| ATP2A2ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 | Altijd | In 1 aandoening |
| CR2complement C3d receptor 2 | Altijd | In 1 aandoening |
| FDX2ferredoxin 2 | Altijd | In 1 aandoening |
| GKglycerol kinase | Altijd | In 1 aandoening |
| HMGCR3-hydroxy-3-methylglutaryl-CoA reductase | Altijd | In 1 aandoening |
| JPH1junctophilin 1 | Altijd | In 1 aandoening |
| KYkyphoscoliosis peptidase | Altijd | In 1 aandoening |
| LPIN1lipin 1 | Altijd | In 1 aandoening |
| MEFVMEFV innate immunity regulator, pyrin | Altijd | In 5 aandoeningen |
| MIEF2mitochondrial elongation factor 2 | Altijd | In 1 aandoening |
| MPV17mitochondrial inner membrane protein MPV17 | Altijd | In 1 aandoening |
| POLG2DNA polymerase gamma 2, accessory subunit | Altijd | In 2 aandoeningen |
| RTN2reticulon 2 | Altijd | In 1 aandoening |
| SCN4Asodium voltage-gated channel alpha subunit 4 | Altijd | In 7 aandoeningen |
| SLC25A4solute carrier family 25 member 4 | Altijd | In 2 aandoeningen |
| AMPD1adenosine monophosphate deaminase 1 | Heel vaak (80–99%) | In 1 aandoening |
| AMPD3adenosine monophosphate deaminase 3 | Heel vaak (80–99%) | In 1 aandoening |
| ANO5anoctamin 5 | Heel vaak (80–99%) | In 2 aandoeningen |
| C4Acomplement C4A (Chido/Rodgers blood group) | Heel vaak (80–99%) | In 1 aandoening |
| CASQ1calsequestrin 1 | Heel vaak (80–99%) | In 2 aandoeningen |
| CCR1C-C motif chemokine receptor 1 | Heel vaak (80–99%) | In 1 aandoening |
| CNBPCCHC-type zinc finger nucleic acid binding protein | Heel vaak (80–99%) | In 2 aandoeningen |
| CPT2carnitine palmitoyltransferase 2 | Heel vaak (80–99%) | In 3 aandoeningen |
| DMDdystrophin | Heel vaak (80–99%) | In 3 aandoeningen |
| DTNAdystrobrevin alpha | Heel vaak (80–99%) | In 1 aandoening |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Heel vaak (80–99%) | In 1 aandoening |
| FASFas cell surface death receptor | Heel vaak (80–99%) | In 1 aandoening |
| GLAgalactosidase alpha | Heel vaak (80–99%) | In 1 aandoening |
| GYS1glycogen synthase 1 | Heel vaak (80–99%) | In 1 aandoening |
| HLA-Bmajor histocompatibility complex, class I, B | Heel vaak (80–99%) | In 3 aandoeningen |
| IFNGR1interferon gamma receptor 1 | Heel vaak (80–99%) | In 1 aandoening |
| IL10interleukin 10 | Heel vaak (80–99%) | In 1 aandoening |
| IL12Ainterleukin 12A | Heel vaak (80–99%) | In 1 aandoening |
| IL12A-AS1IL12A antisense RNA 1 | Heel vaak (80–99%) | In 1 aandoening |
| IL23Rinterleukin 23 receptor | Heel vaak (80–99%) | In 1 aandoening |
| KLRC4killer cell lectin like receptor C4 | Heel vaak (80–99%) | In 1 aandoening |
| LBRlamin B receptor | Heel vaak (80–99%) | In 1 aandoening |
| MVKmevalonate kinase | Heel vaak (80–99%) | In 2 aandoeningen |
| NLRP3NLR family pyrin domain containing 3 | Heel vaak (80–99%) | In 5 aandoeningen |
| OBSCNobscurin, cytoskeletal calmodulin and titin-interacting RhoGEF | Heel vaak (80–99%) | In 1 aandoening |
Toon nog 136 genen
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| ORAI1ORAI calcium release-activated calcium modulator 1 | Heel vaak (80–99%) | In 1 aandoening |
| PLAAT3phospholipase A and acyltransferase 3 | Heel vaak (80–99%) | In 1 aandoening |
| STAT4signal transducer and activator of transcription 4 | Heel vaak (80–99%) | In 2 aandoeningen |
| STIM1stromal interaction molecule 1 | Heel vaak (80–99%) | In 2 aandoeningen |
| TLR4toll like receptor 4 | Heel vaak (80–99%) | In 1 aandoening |
| TNFRSF1ATNF receptor superfamily member 1A | Heel vaak (80–99%) | In 2 aandoeningen |
| UBAC2UBA domain containing 2 | Heel vaak (80–99%) | In 1 aandoening |
| ACAD9acyl-CoA dehydrogenase family member 9 | Vaak (30–79%) | In 1 aandoening |
| ADA2adenosine deaminase 2 | Vaak (30–79%) | In 1 aandoening |
| ALDOAaldolase, fructose-bisphosphate A | Vaak (30–79%) | In 1 aandoening |
| APCAPC regulator of Wnt signaling pathway | Vaak (30–79%) | In 1 aandoening |
| ARVCFARVCF delta catenin family member | Vaak (30–79%) | In 1 aandoening |
| CCDC78coiled-coil domain containing 78 | Vaak (30–79%) | In 1 aandoening |
| CD4CD4 molecule | Vaak (30–79%) | In 1 aandoening |
| CLCN1chloride voltage-gated channel 1 | Vaak (30–79%) | In 3 aandoeningen |
| COMTcatechol-O-methyltransferase | Vaak (30–79%) | In 1 aandoening |
| CRPPACDP-L-ribitol pyrophosphorylase A | Vaak (30–79%) | In 2 aandoeningen |
| CTNNB1catenin beta 1 | Vaak (30–79%) | In 1 aandoening |
| DNA2DNA replication helicase/nuclease 2 | Vaak (30–79%) | In 2 aandoeningen |
| ENO3enolase 3 | Vaak (30–79%) | In 2 aandoeningen |
| FKRPfukutin related protein | Vaak (30–79%) | In 3 aandoeningen |
| FKTNfukutin | Vaak (30–79%) | In 1 aandoening |
| GP1BBglycoprotein Ib platelet subunit beta | Vaak (30–79%) | In 1 aandoening |
| HADHBhydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta | Vaak (30–79%) | In 2 aandoeningen |
| HIRAhistone cell cycle regulator | Vaak (30–79%) | In 1 aandoening |
| IL12Binterleukin 12B | Vaak (30–79%) | In 1 aandoening |
| IRF4interferon regulatory factor 4 | Vaak (30–79%) | In 1 aandoening |
| JMJD1Cjumonji domain containing 1C | Vaak (30–79%) | In 1 aandoening |
| LPIN2lipin 2 | Vaak (30–79%) | In 1 aandoening |
| MDM4MDM4 regulator of p53 | Vaak (30–79%) | In 1 aandoening |
| MLXMAX dimerization protein MLX | Vaak (30–79%) | In 1 aandoening |
| MOCOSmolybdenum cofactor sulfurase | Vaak (30–79%) | In 1 aandoening |
| MRPS2mitochondrial ribosomal protein S2 | Vaak (30–79%) | In 1 aandoening |
| MSTO1misato mitochondrial distribution and morphology regulator 1 | Vaak (30–79%) | In 2 aandoeningen |
| MTTPmicrosomal triglyceride transfer protein | Vaak (30–79%) | In 1 aandoening |
| MYH7myosin heavy chain 7 | Vaak (30–79%) | In 2 aandoeningen |
| NLRC4NLR family CARD domain containing 4 | Vaak (30–79%) | In 1 aandoening |
| NLRP12NLR family pyrin domain containing 12 | Vaak (30–79%) | In 1 aandoening |
| NOD2nucleotide binding oligomerization domain containing 2 | Vaak (30–79%) | In 1 aandoening |
| OTULINOTU deubiquitinase with linear linkage specificity | Vaak (30–79%) | In 1 aandoening |
| PACSIN3protein kinase C and casein kinase substrate in neurons 3 | Vaak (30–79%) | In 1 aandoening |
| PFKMphosphofructokinase, muscle | Vaak (30–79%) | In 1 aandoening |
| PGAM2phosphoglycerate mutase 2 | Vaak (30–79%) | In 1 aandoening |
| PHKA1phosphorylase kinase regulatory subunit alpha 1 | Vaak (30–79%) | In 1 aandoening |
| PHKG1phosphorylase kinase catalytic subunit gamma 1 | Vaak (30–79%) | In 1 aandoening |
| PNPLA2patatin like domain 2, triacylglycerol lipase | Vaak (30–79%) | In 2 aandoeningen |
| POLR3ARNA polymerase III subunit A | Vaak (30–79%) | In 1 aandoening |
| POMT1protein O-mannosyltransferase 1 | Vaak (30–79%) | In 1 aandoening |
| PRDM5PR/SET domain 5 | Vaak (30–79%) | In 1 aandoening |
| PTPN6protein tyrosine phosphatase non-receptor type 6 | Vaak (30–79%) | In 1 aandoening |
| RNASEH1ribonuclease H1 | Vaak (30–79%) | In 2 aandoeningen |
| RREB1ras responsive element binding protein 1 | Vaak (30–79%) | In 1 aandoening |
| RRM2Bribonucleotide reductase regulatory TP53 inducible subunit M2B | Vaak (30–79%) | In 2 aandoeningen |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Vaak (30–79%) | In 1 aandoening |
| SEC24CSEC24 homolog C, COPII component | Vaak (30–79%) | In 1 aandoening |
| SH3TC2SH3 domain and tetratricopeptide repeats 2 | Vaak (30–79%) | In 1 aandoening |
| SVILsupervillin | Vaak (30–79%) | In 1 aandoening |
| TBX1T-box transcription factor 1 | Vaak (30–79%) | In 1 aandoening |
| TRAPPC11trafficking protein particle complex subunit 11 | Vaak (30–79%) | In 3 aandoeningen |
| UFD1ubiquitin recognition factor in ER associated degradation 1 | Vaak (30–79%) | In 1 aandoening |
| VCPvalosin containing protein | Vaak (30–79%) | In 1 aandoening |
| VWA1von Willebrand factor A domain containing 1 | Vaak (30–79%) | In 1 aandoening |
| ACP5acid phosphatase 5, tartrate resistant | Soms (5–29%) | In 1 aandoening |
| AIPAHR interacting HSP90 co-chaperone | Soms (5–29%) | In 1 aandoening |
| ALDH4A1aldehyde dehydrogenase 4 family member A1 | Soms (5–29%) | In 1 aandoening |
| ANK1ankyrin 1 | Soms (5–29%) | In 1 aandoening |
| ANKRD55ankyrin repeat domain 55 | Soms (5–29%) | In 1 aandoening |
| ASXL1ASXL transcriptional regulator 1 | Soms (5–29%) | In 1 aandoening |
| CAVIN1caveolae associated protein 1 | Soms (5–29%) | In 1 aandoening |
| CD247CD247 molecule | Soms (5–29%) | In 1 aandoening |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Soms (5–29%) | In 1 aandoening |
| DCCDCC netrin 1 receptor | Soms (5–29%) | In 1 aandoening |
| DGUOKdeoxyguanosine kinase | Soms (5–29%) | In 1 aandoening |
| DNAJB6DnaJ heat shock protein family (Hsp40) member B6 | Soms (5–29%) | In 1 aandoening |
| DNAL4dynein axonemal light chain 4 | Soms (5–29%) | In 1 aandoening |
| DNASE1L3deoxyribonuclease 1L3 | Soms (5–29%) | In 1 aandoening |
| DYSFdysferlin | Soms (5–29%) | In 1 aandoening |
| EPB42erythrocyte membrane protein band 4.2 | Soms (5–29%) | In 1 aandoening |
| EXT1exostosin glycosyltransferase 1 | Soms (5–29%) | In 1 aandoening |
| EXT2exostosin glycosyltransferase 2 | Soms (5–29%) | In 1 aandoening |
| FMR1fragile X messenger ribonucleoprotein 1 | Soms (5–29%) | In 2 aandoeningen |
| GPR101G protein-coupled receptor 101 | Soms (5–29%) | In 1 aandoening |
| HADHAhydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha | Soms (5–29%) | In 2 aandoeningen |
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Soms (5–29%) | In 1 aandoening |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Soms (5–29%) | In 1 aandoening |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Soms (5–29%) | In 1 aandoening |
| HPDL4-hydroxyphenylpyruvate dioxygenase like | Soms (5–29%) | In 1 aandoening |
| HSPG2heparan sulfate proteoglycan 2 | Soms (5–29%) | In 1 aandoening |
| IGHG2immunoglobulin heavy constant gamma 2 (G2m marker) | Soms (5–29%) | In 1 aandoening |
| IGKCimmunoglobulin kappa constant | Soms (5–29%) | In 1 aandoening |
| IL2RAinterleukin 2 receptor subunit alpha | Soms (5–29%) | In 1 aandoening |
| IL2RBinterleukin 2 receptor subunit beta | Soms (5–29%) | In 1 aandoening |
| KITKIT proto-oncogene, receptor tyrosine kinase | Soms (5–29%) | In 1 aandoening |
| LMNAlamin A/C | Soms (5–29%) | In 3 aandoeningen |
| LMNB1lamin B1 | Soms (5–29%) | In 1 aandoening |
| LRP12LDL receptor related protein 12 | Soms (5–29%) | In 1 aandoening |
| MT-TEmitochondrially encoded tRNA-Glu (GAA/G) | Soms (5–29%) | In 1 aandoening |
| MT-TKmitochondrially encoded tRNA-Lys (AAA/G) | Soms (5–29%) | In 1 aandoening |
| NTN1netrin 1 | Soms (5–29%) | In 1 aandoening |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Soms (5–29%) | In 1 aandoening |
| PHKA2phosphorylase kinase regulatory subunit alpha 2 | Soms (5–29%) | In 1 aandoening |
| PHKBphosphorylase kinase regulatory subunit beta | Soms (5–29%) | In 1 aandoening |
| PHKG2phosphorylase kinase catalytic subunit gamma 2 | Soms (5–29%) | In 1 aandoening |
| PLD4phospholipase D family member 4 | Soms (5–29%) | In 1 aandoening |
| POLGDNA polymerase gamma, catalytic subunit | Soms (5–29%) | In 1 aandoening |
| PPARGperoxisome proliferator activated receptor gamma | Soms (5–29%) | In 1 aandoening |
| PRORPprotein only RNase P catalytic subunit | Soms (5–29%) | In 1 aandoening |
| PRTN3proteinase 3 | Soms (5–29%) | In 1 aandoening |
| PTPN2protein tyrosine phosphatase non-receptor type 2 | Soms (5–29%) | In 1 aandoening |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Soms (5–29%) | In 3 aandoeningen |
| RAD51RAD51 recombinase | Soms (5–29%) | In 1 aandoening |
| SLC4A1solute carrier family 4 member 1 (Diego blood group) | Soms (5–29%) | In 1 aandoening |
| SPTA1spectrin alpha, erythrocytic 1 | Soms (5–29%) | In 1 aandoening |
| SPTBspectrin beta, erythrocytic | Soms (5–29%) | In 1 aandoening |
| SRSF2serine and arginine rich splicing factor 2 | Soms (5–29%) | In 1 aandoening |
| TET2tet methylcytosine dioxygenase 2 | Soms (5–29%) | In 1 aandoening |
| TNXBtenascin XB | Soms (5–29%) | In 1 aandoening |
| TWNKtwinkle mtDNA helicase | Soms (5–29%) | In 2 aandoeningen |
| ALMS1ALMS1 centrosome and basal body associated protein | Zelden (1–4%) | In 1 aandoening |
| CAV3caveolin 3 | Zelden (1–4%) | In 2 aandoeningen |
| CLCNKBchloride voltage-gated channel Kb | Zelden (1–4%) | In 1 aandoening |
| DNM1Ldynamin 1L | Zelden (1–4%) | In 1 aandoening |
| FLNCfilamin C | Zelden (1–4%) | In 1 aandoening |
| OPA1OPA1 mitochondrial dynamin like GTPase | Zelden (1–4%) | In 1 aandoening |
| PPIBpeptidylprolyl isomerase B | Zelden (1–4%) | In 1 aandoening |
| SLC12A3solute carrier family 12 member 3 | Zelden (1–4%) | In 1 aandoening |
| CAPN3calpain 3 | Niet vastgelegd | In 1 aandoening |
| COX6B1cytochrome c oxidase subunit 6B1 | Niet vastgelegd | In 1 aandoening |
| DSEdermatan sulfate epimerase | Niet vastgelegd | In 1 aandoening |
| LDHAlactate dehydrogenase A | Niet vastgelegd | In 1 aandoening |
| MYOTmyotilin | Niet vastgelegd | In 1 aandoening |
| PDGFRAplatelet derived growth factor receptor alpha | Niet vastgelegd | In 1 aandoening |
| POPDC1popeye domain cAMP effector 1 | Niet vastgelegd | In 1 aandoening |
| RBCK1RANBP2-type and C3HC4-type zinc finger containing 1 | Niet vastgelegd | In 1 aandoening |
| SCN9Asodium voltage-gated channel alpha subunit 9 | Niet vastgelegd | In 1 aandoening |
| TMEM126Btransmembrane protein 126B | Niet vastgelegd | In 1 aandoening |
Hoe vaak dit voorkomt bij mensen met een van de aandoeningen van het gen, de hoogste frequentie binnen die aandoeningen, zoals de Human Phenotype Ontology dit vastlegt. Deze pagina's beschrijven kenmerken en het onderzoek erachter; het zijn geen diagnose, en over symptomen kunt u het best een arts of genetisch adviseur raadplegen.
Smallere kenmerken
Bredere kenmerken
Waar dit vandaan komt
- De Human Phenotype Ontology, release 2026-09-01: het kenmerk, de namen, de definitie en de genen die ermee verbonden zijn. Meer informatie vindt u op hpo.jax.org.
- Gegevensrelease 2026.10.16-c6eea6bf.
Eén test. Een leven lang antwoorden.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken